» Articles » PMID: 2038995

Gastroduodenal Mucus Gel Thickness in Patients with Helicobacter Pylori: a Method for Assessment of Biopsy Specimens

Overview
Specialty Gastroenterology
Date 1991 Jun 1
PMID 2038995
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The gastroduodenal mucus layer is considered the primary mucosal protective barrier, especially important in the maintenance of a mucosal pH gradient. Thus, the measurement of the mucus layer thickness in various disease states could advance our understanding of gastroduodenal pathophysiology. We present a novel method for measuring the mucus layer in endoscopic biopsy material and compare layer thickness in Helicobacter pylori (HP)-negative and HP-positive specimens. Endoscopic biopsies were obtained from 17 patients with gastroduodenal mucosa harboring HP and from 15 patients without current HP colonization. The thickness of the mucus layer was measured in fresh specimens by the phase-contrast dark-field microscopy technique. In patients with confirmed HP infection, the thickness of the mucus layer (mean +/- SD) was 0.093 +/- 0.033 mm in duodenal, 0.085 +/- 0.027 mm in antral, and 0.105 +/- 0.033 mm in corporal mucosa. In patients without concomitant HP colonization, the thickness of the mucus gel was 0.162 +/- 0.045 mm, 0.175 +/- 0.067 mm, and 0.161 +/- 0.064 mm in duodenum, antrum, and corpus, respectively. The differences between the means were statistically significant (p less than 0.001 for the duodenal, p less than 0.001 for antral, and p less than 0.01 for corporal mucosa). This study suggests that colonization of the gastroduodenal mucosa by HP impairs the mucus layer covering the surface epithelium. This mucus layer impairment may lead to mucosal injury with subsequent development of inflammation and, possibly, peptic ulcer disease.

Citing Articles

Protective Factors of the Gastric and Duodenal Mucosa: An Overview.

Yandrapu H, Sarosiek J Curr Gastroenterol Rep. 2015; 17(6):24.

PMID: 26109006 DOI: 10.1007/s11894-015-0452-2.


Stimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication.

Majewski M, Sarosiek I, Wallner G, Edlavitch S, Sarosiek J Clin Transl Gastroenterol. 2014; 5:e66.

PMID: 25521039 PMC: 4274370. DOI: 10.1038/ctg.2014.19.


Impairment of salivary mucin production resulting in declined salivary viscosity during naproxen administration as a potential link to upper alimentary tract mucosal injury.

Garcia C, Castro-Combs J, Dias A, Alfaro R, Vasallo J, Majewski M Clin Transl Gastroenterol. 2013; 4:e40.

PMID: 23884372 PMC: 3724045. DOI: 10.1038/ctg.2013.8.


Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.

Gorrell R, Robins-Browne R Infect Immun. 2009; 77(11):5116-29.

PMID: 19737910 PMC: 2772510. DOI: 10.1128/IAI.00547-09.


Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.

Iijima K, Ichikawa T, Okada S, Ogawa M, Koike T, OHara S Dig Dis Sci. 2008; 54(7):1500-7.

PMID: 18975081 PMC: 2690849. DOI: 10.1007/s10620-008-0507-4.